Drug intelligence / Profile preview

isosorbide mononitrate

Development stage
Approved
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Oral
01

Overview

Isosorbide mononitrate is a small molecule antianginal agent in the nitrate class used primarily to prevent angina pectoris (chest pain) associated with coronary artery disease. It acts as a prodrug for nitric oxide (NO), which induces vasodilation by relaxing vascular smooth muscle. This process involves activation of soluble guanylyl cyclase in vascular endothelial cells, leading to increased cyclic GMP levels and subsequent smooth muscle relaxation through reduced intracellular calcium concentrations. The result is dilation of both peripheral veins and arteries, reducing cardiac preload and afterload while improving coronary blood flow. Isosorbide mononitrate does not provide immediate relief for acute angina attacks but is effective for long-term prevention[1][3][4][5].

Brand names
ImdurMonoketISMO
Other names
ISMN
02

Targets

GUCY1A2 (Guanylate cyclase soluble subunit alpha-2)

Beyond the preview

Go deeper on isosorbide mononitrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isosorbide mononitrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call